Furthermore, we showed a significant association between active TGF-β1 serum levels and vascular (digital ulcers) and fibrotic (lung and skin) manifestations in SSc patients, suggesting that raised levels could be evaluated as a marker of advanced disease. The gene discussed is TGFB1; the disease is systemic sclerosis.